Skip to main content
. 2017 Jul 3;7(6):e015081. doi: 10.1136/bmjopen-2016-015081

Figure 1.

Figure 1

Flow diagram showing the trial decision guidelines for the run-in period of the trial design, incorporating a conventional 3+3 cohort design if dose escalation is required.